Schneider M, Narciso-Abraham M, Hadl S, McMahon R, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2023 Jun 12:S0140-6736(23)00641-4. doi: 10.1016/S0140-6736(23)00641.
PMID: 37321235